CRISPR Knock-in Mouse Debuts

Researchers have created a line of model mice that naturally express Cas9, paving the way for rapid precision gene-editing.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, RAMAThe work of researchers who use the CRISPR gene-editing technique to precisely clip genetic sequences from mouse chromosomes just got a little bit easier. Scientists at the Broad Institute of MIT and Harvard have unveiled the “Cas9 mouse,” a model organism that naturally expresses Cas9, the cleaving enzyme that cuts DNA in exact spots along the genome with the help of a guide RNA. Currently, using CRISPR means injecting both Cas9 and guide RNA into cells to edit a specific part of the genome. But with Cas9 mice, researchers will only have to inject the guide RNA, which pilots the Cas9 to the target gene sequence, in order to alter virtually any part of the mouse genome.

This will allow quicker and easier gene knock-down experiments, for example, because having on-board Cas9 makes more room in vectors used to deliver the guide RNA to contain multiple instructions for genome editing in the knock-in mice. “By equipping the mouse with Cas9, we relieved the burden of delivery,” MIT’s Randall Platt, a coauthor on the September 25 Cell paper announcing the creation of the Cas9 mouse, said in a statement. “This frees up space for the delivery of additional elements—whether by viruses or nanoparticles—making it possible to simultaneously mutate multiple genes and even make precise changes in DNA sequences.”

No longer will researchers seeking to mouse lines that model human cancers, for instance, have to inactivate one gene at a time or cross animals ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control